FDA de­lays Dupix­ent in COPD de­ci­sion by three months while EMA gives thumbs-up

Sanofi and Re­gen­eron will have to wait three more months for a ma­jor FDA de­ci­sion on ex­pand­ing Dupix­ent’s la­bel, the com­pa­nies dis­closed Fri­day morn­ing. Mean­while …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.